b 928 7 1/2
Generic Name: methotrexate
Pill imprint b 928 7 1/2 has been identified as Trexall 7.5 mg.
Trexall is used in the treatment of psoriasis; rheumatoid arthritis; brain tumor; breast cancer; ectopic pregnancy (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy.
Trexall 7.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Trexall Images
- Generic Name:
- methotrexate
- Imprint:
-
b
928 7 1/2 - Strength:
- 7.5 mg
- Color:
- Blue
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
More Trexall resources
Trexall is associated with the treatment of:
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia
- Acute Nonlymphocytic Leukemia
- Bladder Cancer
- Brain Tumor
- Breast Cancer
- Bullous Pemphigoid
- Cervical Cancer
- Choriocarcinoma
- Cogan's Syndrome
- Colorectal Cancer
- Dermatomyositis
- Ectopic Pregnancy
- Eczema
- Esophageal Carcinoma
- Gastric Cancer
- Graft-versus-host disease
- Head and Neck Cancer
- Hodgkin's Lymphoma
- Lymphoma
- Meningeal Leukemia
- Mycosis Fungoides
- Neoplastic Diseases
- Non-Hodgkin's Lymphoma
- Non-Small Cell Lung Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancreatic Cancer
- Pemphigoid
- Pemphigus
- Psoriasis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Small Cell Lung Cancer
- Soft Tissue Sarcoma
- Solid Tumors
- Systemic Sclerosis
- Trophoblastic Disease
- Uveitis


